Cosmax Group announced the launch of "Cosmax BF" to collaborate with other cosmetics companies and industries for the development of new technology for skin products. The newly set up alliance will focus on biomaterial development and research on biotechnology beyond the skin microbiome.
Cosmax Group said it will pursue partnerships with companies and work on microbiome, biosynthetic strains, and natural emulsifiers. The company confirmed its new Bio Foundry on Monday, Feb. 5, and said this is an intra-group group for biomaterial R&D, per The Korea Economic Daily.
Cosmax BF Bio Foundry
The new alliance was formed with three corporate members: CM Tech, Cosmax BTI R&I (Research & Innovation) Center, and Cosmax AB, a new Active Biome joint venture. Along with these companies, the Cosmax BF will have 100 researchers from local and global universities. They are all expected to participate in open research for microbiome cosmetics.
Cosmax Group is known as an original design manufacturing (ODM) cosmetics firm in South Korea, and its new integrated R&D center for biomaterial was formed to combine or merge the company's existing bioexpertise. It is also meant to promote collaborative efforts among internal research groups.
About Cosmax
Korea's The Yakup News reported that the Cosmax Group started researching the skin microbiome in 2011 and commercialized the first skin microbiome cosmetics in 2019. It was a very successful debut; in 2022, the cosmetics ODM brand launched the second generation of skin microbiome called Strain CX, a flora collected from thousands of people's skin.
"Currently, large global customers are competing to develop cosmetics that take into account not only efficacy but also the environment using organisms," a Cosmax Group official said in a press release. "Through the launch of Cosmax BF, we will significantly strengthen the group's bio capabilities to gain an upper hand in future cosmetics competition."
Photo by: Cosmax Press Release


Super Micro Stock Jumps 19% as AI Server Demand Drives Strong 2027 Outlook
Apple Develops China-Specific AI Model With Alibaba as Apple Intelligence Launch Nears
Anthropic Eyes $6B Decart AI Acquisition Ahead of Mega IPO
Micron Stock Upgraded to Buy as New Street Sees $2 Trillion Valuation Potential
Sanrio Shares Plunge as Q1 Profit Miss Overshadows Strong Sales
Aviva First-Half Operating Profit Jumps 24% as Direct Line Deal Boosts Growth
Bernstein Picks BYD and Xiaomi as Top China EV Stocks Despite Weaker Demand
Australia’s Corporate Leaders Face Parliament Over KPMG Client Data Scandal
Paramount Weighs CNN Sale as $110B Warner Bros. Discovery Deal Faces Antitrust Fight
Bank of America to Buy Up to 49.9% Stake in Jio Credit for $1.92 Billion
China Automakers Accelerate Global Expansion as Domestic Car Sales Slump
ANZ Home Loan Applications Drop 12% After Australia Property Tax Changes
SMIC Shares Rally as Q2 Profit Surges 262% on Strong Chip Demand
Google Pushes Gemini AI Overhaul as Sergey Brin Targets Model Supremacy
Paramount Skydance Clears Regulatory Hurdles for Warner Bros. Discovery Deal
Goldman Sachs Eyes Investors for Nvidia’s $500 Billion AI Financing Plan 



